Pancreatic cancer genetic marker may predict outcomes with radiation therapy

scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. The discovery may help physicians provide better treatment options for patients.

Go to Source

(Visited 1 times, 1 visits today)

Site Footer

Sliding Sidebar